Exploration of the diagnostic utility of next generation sequencing with TruSight cancer panel for BRCA negative hereditary breast and ovarian cancer patients

被引：0
|
作者：
Dacheva, D.
Dodova, R.
Mitkova, A.
Kamenarova, K.
Tzveova, R.
Popov, I.
Vlahova, A.
Taushanova-Hadjieva, M.
Valev, S.
Dikov, T.
Timcheva, K.
Christova, S.
Mitev, V.
Kaneva, R.
机构：
[1] Med Univ Sofia, Fac Med, Mol Med Ctr, Sofia, Bulgaria
[2] Med Univ Sofia, Univ Hosp Alexandrovska, Gen & Clin Pathol Clin, Sofia, Bulgaria
[3] Nadezhda Womens Hlth Hosp, Clin Med Oncol Chemotherapy, Sofia, Bulgaria
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.SABCS15-P2-09-18
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-09-18
引用
收藏
页数：2
相关论文
共 50 条
  • [31] New recurrent BRCA1/2 mutations in Polish patients with familial breast/ovarian cancer detected by next generation sequencing
    Kluska, Anna
    Balabas, Aneta
    Paziewska, Agnieszka
    Kulecka, Maria
    Nowakowska, Dorota
    Mikula, Michal
    Ostrowski, Jerzy
    BMC MEDICAL GENOMICS, 2015, 8
  • [32] New recurrent BRCA1/2 mutations in Polish patients with familial breast/ovarian cancer detected by next generation sequencing
    Anna Kluska
    Aneta Balabas
    Agnieszka Paziewska
    Maria Kulecka
    Dorota Nowakowska
    Michal Mikula
    Jerzy Ostrowski
    BMC Medical Genomics, 8
  • [33] Hereditary breast cancer next-generation sequencing panel evaluation in the south region of Brazil: A novel BRCA2 candidate pathogenic variant is reported
    Duarte, Cesar Augusto B.
    dos Santos, Carlos Alberto
    de Oliveira, Cristine Domingues D.
    Spautz, Cleverton Cesar
    Sumita, Laura Masami
    Nakatani, Sueli Massumi
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2024, 12 (08):
  • [34] IDENTIFICATION OF BRCA1/2 MUTATIONS IN BREAST CANCER PATIENTS BY NEXT-GENERATION SEQUENCING
    Stetsenko, I. F.
    Krasnenko, A. Yu
    Stanoevich, U. S.
    Mescheryakov, A. A.
    Vorotnikov, I. K.
    Druzhilovskaya, O. S.
    Belova, V. A.
    Churov, A., V
    BULLETIN OF RUSSIAN STATE MEDICAL UNIVERSITY, 2018, (06): : 183 - 189
  • [35] Impact of Panel Gene Testing for Hereditary Breast and Ovarian Cancer on Patients
    Lumish, Heidi S.
    Steinfeld, Hallie
    Koval, Carrie
    Russo, Donna
    Levinson, Elana
    Wynn, Julia
    Duong, James
    Chung, Wendy K.
    JOURNAL OF GENETIC COUNSELING, 2017, 26 (05) : 1116 - 1129
  • [36] OLA1 gene sequencing in patients with BRCA1/2 mutation-negative suspected hereditary breast and ovarian cancer
    Masanobu Takahashi
    Natsuko Chiba
    Hideki Shimodaira
    Yuki Yoshino
    Takahiro Mori
    Makiko Sumii
    Tadashi Nomizu
    Chikashi Ishioka
    Breast Cancer, 2017, 24 : 336 - 340
  • [37] OLA1 gene sequencing in patients with BRCA1/2 mutation-negative suspected hereditary breast and ovarian cancer
    Takahashi, Masanobu
    Chiba, Natsuko
    Shimodaira, Hideki
    Yoshino, Yuki
    Mori, Takahiro
    Sumii, Makiko
    Nomizu, Tadashi
    Ishioka, Chikashi
    BREAST CANCER, 2017, 24 (02) : 336 - 340
  • [38] Next-generation sequencing of a panel of genes contributing to breast cancer risk
    Uhrhammer, Nancy A.
    El Saghir, Nagi
    Bidet, Yannick
    Delahaye-Sourdeix, Manon
    Ponelle, Flora
    Ollier, Marie
    Viala, Sandrine
    Kreidieh, Firas
    Khoueiry-Zgheib, Nathalie
    Bignon, Yves-Jean
    CANCER RESEARCH, 2016, 76
  • [39] Detection of clinically important BRCA gene mutations in ovarian cancer patients using next generation sequencing analysis
    Zhang, Yiping
    Ali, Akbar
    Xie, Jun
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (10): : 5005 - +
  • [40] BRCA testing of 1,284 Brazilian patients for hereditary breast and ovarian cancer in a routine diagnostic setting
    Milanezi, F.
    Silva, J. S.
    de Marsillac, S. M.
    Monfredini, P. M.
    Nakano, V.
    D'Andrea, M. G.
    Guarischi-Sousa, R.
    Schnabel, B.
    Correia, W. D.
    Campana, G. A.
    da Fonseca, G. G.
    Perrone, E.
    Zalcberg, I.
    ANNALS OF ONCOLOGY, 2019, 30
12345